{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:32:30Z","timestamp":1771054350007,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejso.2014.08.471","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T04:15:33Z","timestamp":1408508133000},"page":"1195-1202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of sentinel node tumor burden on outcome of invasive breast cancer patients"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1861-2895","authenticated-orcid":false,"given":"I.","family":"Meattini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Saieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Francolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Greto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Orzalesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fambrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Livi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2014.08.471_bib1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2014.08.471_bib2","first-page":"250","article-title":"Conservative treatment of early breast cancer: long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy","volume":"211","author":"Veronesi","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2014.08.471_bib3","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","article-title":"Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update","volume":"52","author":"Fisher","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2014.08.471_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2014.08.471_bib5","series-title":"AJCC cancer staging manual","year":"2010"},{"key":"10.1016\/j.ejso.2014.08.471_bib6","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1245\/s10434-007-9513-6","article-title":"The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis","volume":"14","author":"Chen","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jamcollsurg.2008.10.036","volume":"208","author":"Reed","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2014.08.471_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/SLA.0b013e31823dc616","article-title":"Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells","volume":"255","author":"Pepels","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2014.08.471_bib9","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1245\/s10434-012-2386-3","article-title":"Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment","volume":"19","author":"Milgrom","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ejso.2014.08.471_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2013.02.009","article-title":"Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy","volume":"108","author":"Livi","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib12","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1002\/cncr.26647","article-title":"Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a\/T1b, lymph node-negative breast cancer","volume":"118","author":"Livi","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2014.08.471_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejso.2013.12.011","article-title":"The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases","volume":"40","author":"Meattini","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clbc.2013.02.005","article-title":"Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen","volume":"13","author":"Meattini","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ejso.2014.08.471_bib15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/bjc.1989.200","article-title":"Ki67 immunostaining in primary breast cancer: pathological and clinical associations","volume":"59","author":"Bouzubar","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2014.08.471_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2559.2002.14691.x","article-title":"Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer\u2014experience from a large study with long-term follow-up","volume":"41","author":"Elston","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2014.08.471_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-012-2040-6","article-title":"Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer","volume":"134","author":"Munzone","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2014.08.471_bib18","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer Working Group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2014.08.471_bib19","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/0959-8049(92)90534-9","article-title":"Axillary dissection of level I and II lymph nodes is important in breast cancer classification","volume":"28","author":"Axelsson","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2014.08.471_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.1999.17.1.143","article-title":"Physical and psychological morbidity after axillary lymph node dissection for breast Cancer","volume":"17","author":"Hack","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejca.2013.11.024","article-title":"When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node?","volume":"50","author":"Suyoi","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2014.08.471_bib22","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1200\/JCO.2008.19.0686","article-title":"Impact of micrometastases in the sentinel node of patients with invasive breast cancer","volume":"27","author":"Hansen","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa0904832","article-title":"Micrometastases or isolated tumor cells and the outcome of breast cancer","volume":"361","author":"de Boer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2014.08.471_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1200\/JCO.2005.07.094","article-title":"Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement","volume":"23","author":"Colleoni","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","article-title":"Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009","volume":"20","author":"Goldhirsch","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib26","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes \u2013 dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/annonc\/mdn535","article-title":"Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study","volume":"20","author":"Gobardhan","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejso.2006.09.003","article-title":"Predictors of axillary lymph node metastasis in breast cancer a systematic review","volume":"33","author":"Patani","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cncr.20809","article-title":"Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution","volume":"103","author":"Viale","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2014.08.471_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1445-1433.2001.02266.x","article-title":"Predictors of axillary lymph node metastases in invasive breast cancer","volume":"71","author":"Chua","year":"2001","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ejso.2014.08.471_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.breast.2012.09.003","article-title":"Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice","volume":"22","author":"Yoshihara","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2014.08.471_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00066-005-1374-y","article-title":"Prediction of axillary lymph node status of breast cancer patients by tumor biological factors of the primary tumor","volume":"181","author":"Fehm","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ejso.2014.08.471_bib34","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1200\/JCO.2007.11.9479","article-title":"Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer","volume":"26","author":"Katz","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/SLA.0b013e318238f461","article-title":"Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node","volume":"255","author":"Mittendorf","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2014.08.471_bib36","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1245\/s10434-010-0945-z","article-title":"Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial","volume":"17","author":"Straver","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2014.08.471_bib38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1008108","article-title":"Effect of occult metastases on survival in node-negative breast cancer","volume":"364","author":"Weaver","year":"2011","journal-title":"N\u00a0Engl J Med"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831401052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831401052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:13:42Z","timestamp":1565741622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879831401052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S074879831401052X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2014.08.471","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of sentinel node tumor burden on outcome of invasive breast cancer patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2014.08.471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}